{"mainPropery":{"diseaseId":3652,"diseaseName":"Microscopic polyangiitis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/3652/microscopic-polyangiitis","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"ORPHANET","identifierId":"727"},{"identifierType":"UMLS","identifierId":"C0343192"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":26,"diseaseTypeName":"Kidney and Urinary Diseases","source":"Orphanet"},{"diseaseTypeId":21,"diseaseTypeName":"Lung Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":33,"diseaseTypeName":"RDCRN"}],"organizations":[{"resourceID":117,"resourceName":"Vasculitis Foundation","abbreviation":"","address1":"P.O. Box 28660","address2":"","address3":"","address4":"","address5":"","city":"Kansas City","state":"MO","zip":"64188","country":"United States","phone":"+1-816-436-8211 ","tty":"","tollFree":"1-800-277-9474","fax":"+1-816-656-3838","email":"https://www.vasculitisfoundation.org/contact-us-2/","url":"https://www.vasculitisfoundation.org/","freeText":""},{"resourceID":933,"resourceName":"American Autoimmune Related Diseases Association","abbreviation":"AARDA","address1":"19176 Hall Road, Suite 130","address2":"","address3":"","address4":"","address5":"","city":"Clinton Township","state":"MI","zip":"48038","country":"United States","phone":"586-776-3900","tty":"","tollFree":"800-598-4668","fax":"586-776-3903","email":"aarda@aarda.org","url":"https://www.aarda.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=%28Microscopic%5BTitle%5D%20AND%20polyangiitis.%5BTitle%5D%29%20AND%20%22loattrfree%20full%20text%22%5Bsb%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Microscopic polyangiitis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Microscopic+polyangiitis%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Microscopic polyangiitis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":633,"resourceId":1357,"resourceName":"All Star Vasculitis Patient Symposium","descriptionText":"<a href='http://www.vasculitisfoundation.org/node/2998 ' target='_blank'>All Star Vasculitis Patient Symposium<br /></a>July 30, 2010 - August 1, 2010<br /><strong>Location:</strong> Westin Long Beach Hotel in Long Beach, California<br /><strong>Description: </strong>Topics will cover all the types of vasculitis and will concentrate on the advances in medical treatments, research, and quality of life of patients. The meeting attracts vasculitis patients, family members, and medical vasculitis experts in the world.","resourceClassificationName":"News & Events","resourceClassificationSectionName":"Other Conferences"},{"id":774,"resourceId":1459,"resourceName":"Vasculitis - Medical consultants Vasculitis foundation","descriptionText":"If your physician would like to review your case with a vasculitis specialist, the <a href='http://www.vasculitisfoundation.org/mcm_resources/medical-consultants/' target='_blank'>Vasculitis Foundation</a> lists vasculitis medical consultants that may be able to speak with your healthcare provider. Click on the link above to learn more.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":987,"resourceId":1682,"resourceName":"Microscopic polyangitis - Vasculitis Foundation","descriptionText":"The <a href='http://www.vasculitisfoundation.org/education/forms/microscopic-polyangiitis/' target='_blank'>Vasculitis Foundation</a> has an information page on microscopic polyangiitis on their Web site.  Click on the Vasculitis Foundation link to view this information.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1375,"resourceId":2025,"resourceName":"Microscopic polyangiitis - The Johns Hopkins Vasculitis Center","descriptionText":"<a href='http://www.hopkinsvasculitis.org/types-vasculitis/microscopic-polyangiitis/' target='_blank'>The <?xml:namespace prefix = st1 ns = urn:schemas-microsoft-com:office:smarttags /><st1:place w:st=on><st1:PlaceName w:st=on>Johns</st1:PlaceName> <st1:PlaceName w:st=on>Hopkins</st1:PlaceName> Vasculitis <st1:PlaceType w:st=on>Center</st1:PlaceType></st1:place></a> Web site has an information page on microscopic polyangiitis.&nbsp; Click on the Johns <st1:PlaceName w:st=\"on\">Hopkins</st1:PlaceName>&nbsp;link to view this information.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1376,"resourceId":2026,"resourceName":"The Cleveland Clinic","descriptionText":"The <a href='http://my.clevelandclinic.org/disorders/microscopic_polyangiitis/hic_microscopic_polyangitis.aspx' target='_blank'>Cleveland Clinic</a> Web site has an&nbsp;information page on Microscopic polyangiitis. Click on the Cleveland Clinic link to view this page.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1377,"resourceId":2027,"resourceName":"RDCRN - Vasculitis Clinical Research Consortium (VCRC)","descriptionText":"The <a href='https://www.rarediseasesnetwork.org/cms/vcrc' target='_blank'>Vasculitis Clinical Research Consortium</a> (VCRC) is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research in different forms of vasculitis. The VCRC has a contact registry for patients who wish to be contacted about clinical research opportunities and updates on the progress of the VCRC research projects.<br /><br />For more information on the registry see: <a href='https://www.rarediseasesnetwork.org/cms/vcrc/About-Us' target='_blank'>https://www.rarediseasesnetwork.org/cms/vcrc/About-Us</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/vasculitis.html' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Vasculitis-Syndromes-Central-and-Peripheral' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicine.com/med/topic2931.htm' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=727' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:727' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2233,"resourceId":117,"resourceName":"Vasculitis Foundation","descriptionText":"The&nbsp;<a href='http://www.vasculitisfoundation.org/map-2/' target='_blank'>Vasculitis Foundation</a> has a \"Find a Physician\" map on its website.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":2781,"resourceId":4265,"resourceName":"Autoimmune Registry","descriptionText":"The <a href='http://www.autoimmuneregistry.org/' target='_blank'>Autoimmune Registry</a> supports research for Microscopic polyangiitis by collecting information about patients with this and other autoimmune diseases. You can join the registry to share your information with researchers and receive updates about participating in new research studies.&nbsp;<a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries.</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":423,"questionText":"What is microscopic polyangiitis (MPA)?","answerText":"<strong>Microscopic polyangiitis (MPA) </strong>is a disorder that causes blood vessel inflammation (<a href=\"http://www.nlm.nih.gov/medlineplus/vasculitis.html\" target=\"_blank\">vasculitis</a>),&nbsp;which can lead to&nbsp;organ damage.[294]&nbsp;The kidneys, lungs, nerves, skin, and joints are the most commonly affected areas of the body. MPA is diagnosed in people of all ages, all&nbsp;ethnicities, and both genders.[295] The cause of this disorder is unknown.","dateModified":"2014-08-13T00:00:00"},"basicQuestions":[{"questionId":424,"questionText":"What are the symptoms of microscopic polyangiitis (MPA)?","answerText":"The symptoms of MPA depend on which blood vessels are involved and what organs in the body are affected. The most common symptoms of&nbsp;MPA include&nbsp;kidney inflammation, weight loss, skin lesions, nerve damage, and fevers.[295] Other symptoms depending on the area(s) of the body affected may include:[298]<br />\r\n<ul>\r\n    <li>Skin-Rash</li>\r\n    <li>Lungs-cough, breathing problems, spitting up blood</li>\r\n    <li>Gastrointestinal-bleeding in the gastrointestinal tract, abdominal pain</li>\r\n    <li>Brain/neurological-tingling, pain, weakness, loss of sensation, seizures</li>\r\n    <li>Musculoskeletal-joint pain, muscle pain</li>\r\n</ul>","dateModified":"2016-07-06T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":295,"authors":"","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"The Johns Hopkins Vasculitis Center Web site","date":"2014","volume":"","pages":"","url":"http://www.hopkinsvasculitis.org/types-vasculitis/microscopic-polyangiitis/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":298,"authors":"Farid-Moayer M","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"Medscape","date":"December 21, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/334024-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":425,"questionText":"What causes microscopic polyangiitis (MPA)?","answerText":"The cause of MPA is unknown. It is not contagious, does not usually run in families, and is not a form of cancer. The <a href=\"http://kidshealth.org/parent/general/body_basics/immune.html\" target=\"_blank\">immune system</a> is thought to play a critical role in the development of&nbsp;MPA.&nbsp; It is thought that&nbsp;the immune system becomes overactive and causes blood vessel and tissue inflammation, which leads to organ damage.&nbsp;It is not&nbsp;known what causes&nbsp;the immune system to become overactive.[294]","dateModified":"2014-08-13T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":294,"authors":"","articleTitle":"Microscopic Polyangiitis","bookWebsiteJournalTitle":"Cleveland Clinic Web site","date":"2/27/2014","volume":"","pages":"","url":"http://my.clevelandclinic.org/health/diseases_conditions/hic_Microscopic_Polyangitis","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":426,"questionText":"How might microscopic polyangiitis (MPA) be treated?","answerText":"The treatment of MPA is dependent on the extent of the disease, rate of progression, and the degree of inflammation. The goal of treatment is to stop organ damage that occurs as a result of MPA and involves use of medications that suppress the immune system. Treatment is typically carried out in three phases:[294][295][298]<br />\r\n<ol>\r\n    <li>Remission induction using <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601102.html\" target=\"_blank\">prednisone</a> and <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682080.html\" target=\"_blank\">cyclophosphamide</a>. This phase usually lasts between 4 and 6 months.&nbsp;</li>\r\n    <li>Remission maintenance using prednisone and replacing cyclophosphamide with other medications such as <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682019.html\" target=\"_blank\">methotrexate</a> and <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682167.html\" target=\"_blank\">azathioprine</a>. This phases usually lasts between 12 and 24 months.&nbsp;</li>\r\n    <li>Treatment of relapse utilizing medications from phase one or other therapies such as <a href=\"http://primaryimmune.org/treatment-information/immunoglobulin-therapy/\" target=\"_blank\">intravenous immunoglobulin</a> for resistant cases.&nbsp;</li>\r\n</ol>\r\n<br />","dateModified":"2016-07-06T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":294,"authors":"","articleTitle":"Microscopic Polyangiitis","bookWebsiteJournalTitle":"Cleveland Clinic Web site","date":"2/27/2014","volume":"","pages":"","url":"http://my.clevelandclinic.org/health/diseases_conditions/hic_Microscopic_Polyangitis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":295,"authors":"","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"The Johns Hopkins Vasculitis Center Web site","date":"2014","volume":"","pages":"","url":"http://www.hopkinsvasculitis.org/types-vasculitis/microscopic-polyangiitis/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":298,"authors":"Farid-Moayer M","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"Medscape","date":"December 21, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/334024-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":427,"questionText":"What is the long-term outlook for microscopic polyangiitis (MPA)?","answerText":"The prognosis for MPA depends on the severity of the condition. Early diagnosis and prompt treatment lead to a better overall prognosis.[294] With treatment,&nbsp;75 percent of individuals&nbsp;achieve complete remission.[298] After achieving remission, it is possible for MPA to recur (often referred to as a &ldquo;relapse&rdquo;). Relapses occur in about 30-50% of people with MPA.&nbsp;Achieving remission is again possible for most people with MPA.[294][298]<br />","dateModified":"2016-07-06T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":294,"authors":"","articleTitle":"Microscopic Polyangiitis","bookWebsiteJournalTitle":"Cleveland Clinic Web site","date":"2/27/2014","volume":"","pages":"","url":"http://my.clevelandclinic.org/health/diseases_conditions/hic_Microscopic_Polyangitis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":298,"authors":"Farid-Moayer M","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"Medscape","date":"December 21, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/334024-overview","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":13011,"relatedDiseaseName":"ANCA-associated vasculitis","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":12739,"relatedDiseaseName":"Secondary glomerular disease","relation":"Parent","isRare":true,"hasGardPage":false}],"gardCases":[{"caseId":23093,"abbreviatedInquiry":"A member of my family has microscopic polyangiitis. What can you tell me about this condition?","caseQuestions":[{"questionId":423,"questionText":"What is microscopic polyangiitis (MPA)?","answerText":"<strong>Microscopic polyangiitis (MPA) </strong>is a disorder that causes blood vessel inflammation (<a href=\"http://www.nlm.nih.gov/medlineplus/vasculitis.html\" target=\"_blank\">vasculitis</a>),&nbsp;which can lead to&nbsp;organ damage.[294]&nbsp;The kidneys, lungs, nerves, skin, and joints are the most commonly affected areas of the body. MPA is diagnosed in people of all ages, all&nbsp;ethnicities, and both genders.[295] The cause of this disorder is unknown.","dateModified":"2014-08-13T00:00:00","references":[{"referenceId":294,"authors":"","articleTitle":"Microscopic Polyangiitis","bookWebsiteJournalTitle":"Cleveland Clinic Web site","date":"2/27/2014","volume":"","pages":"","url":"http://my.clevelandclinic.org/health/diseases_conditions/hic_Microscopic_Polyangitis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":295,"authors":"","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"The Johns Hopkins Vasculitis Center Web site","date":"2014","volume":"","pages":"","url":"http://www.hopkinsvasculitis.org/types-vasculitis/microscopic-polyangiitis/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":424,"questionText":"What are the symptoms of microscopic polyangiitis (MPA)?","answerText":"The symptoms of MPA depend on which blood vessels are involved and what organs in the body are affected. The most common symptoms of&nbsp;MPA include&nbsp;kidney inflammation, weight loss, skin lesions, nerve damage, and fevers.[295] Other symptoms depending on the area(s) of the body affected may include:[298]<br />\r\n<ul>\r\n    <li>Skin-Rash</li>\r\n    <li>Lungs-cough, breathing problems, spitting up blood</li>\r\n    <li>Gastrointestinal-bleeding in the gastrointestinal tract, abdominal pain</li>\r\n    <li>Brain/neurological-tingling, pain, weakness, loss of sensation, seizures</li>\r\n    <li>Musculoskeletal-joint pain, muscle pain</li>\r\n</ul>","dateModified":"2016-07-06T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":295,"authors":"","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"The Johns Hopkins Vasculitis Center Web site","date":"2014","volume":"","pages":"","url":"http://www.hopkinsvasculitis.org/types-vasculitis/microscopic-polyangiitis/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":298,"authors":"Farid-Moayer M","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"Medscape","date":"December 21, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/334024-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":425,"questionText":"What causes microscopic polyangiitis (MPA)?","answerText":"The cause of MPA is unknown. It is not contagious, does not usually run in families, and is not a form of cancer. The <a href=\"http://kidshealth.org/parent/general/body_basics/immune.html\" target=\"_blank\">immune system</a> is thought to play a critical role in the development of&nbsp;MPA.&nbsp; It is thought that&nbsp;the immune system becomes overactive and causes blood vessel and tissue inflammation, which leads to organ damage.&nbsp;It is not&nbsp;known what causes&nbsp;the immune system to become overactive.[294]","dateModified":"2014-08-13T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":294,"authors":"","articleTitle":"Microscopic Polyangiitis","bookWebsiteJournalTitle":"Cleveland Clinic Web site","date":"2/27/2014","volume":"","pages":"","url":"http://my.clevelandclinic.org/health/diseases_conditions/hic_Microscopic_Polyangitis","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":426,"questionText":"How might microscopic polyangiitis (MPA) be treated?","answerText":"The treatment of MPA is dependent on the extent of the disease, rate of progression, and the degree of inflammation. The goal of treatment is to stop organ damage that occurs as a result of MPA and involves use of medications that suppress the immune system. Treatment is typically carried out in three phases:[294][295][298]<br />\r\n<ol>\r\n    <li>Remission induction using <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601102.html\" target=\"_blank\">prednisone</a> and <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682080.html\" target=\"_blank\">cyclophosphamide</a>. This phase usually lasts between 4 and 6 months.&nbsp;</li>\r\n    <li>Remission maintenance using prednisone and replacing cyclophosphamide with other medications such as <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682019.html\" target=\"_blank\">methotrexate</a> and <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682167.html\" target=\"_blank\">azathioprine</a>. This phases usually lasts between 12 and 24 months.&nbsp;</li>\r\n    <li>Treatment of relapse utilizing medications from phase one or other therapies such as <a href=\"http://primaryimmune.org/treatment-information/immunoglobulin-therapy/\" target=\"_blank\">intravenous immunoglobulin</a> for resistant cases.&nbsp;</li>\r\n</ol>\r\n<br />","dateModified":"2016-07-06T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":294,"authors":"","articleTitle":"Microscopic Polyangiitis","bookWebsiteJournalTitle":"Cleveland Clinic Web site","date":"2/27/2014","volume":"","pages":"","url":"http://my.clevelandclinic.org/health/diseases_conditions/hic_Microscopic_Polyangitis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":295,"authors":"","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"The Johns Hopkins Vasculitis Center Web site","date":"2014","volume":"","pages":"","url":"http://www.hopkinsvasculitis.org/types-vasculitis/microscopic-polyangiitis/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":298,"authors":"Farid-Moayer M","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"Medscape","date":"December 21, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/334024-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":427,"questionText":"What is the long-term outlook for microscopic polyangiitis (MPA)?","answerText":"The prognosis for MPA depends on the severity of the condition. Early diagnosis and prompt treatment lead to a better overall prognosis.[294] With treatment,&nbsp;75 percent of individuals&nbsp;achieve complete remission.[298] After achieving remission, it is possible for MPA to recur (often referred to as a &ldquo;relapse&rdquo;). Relapses occur in about 30-50% of people with MPA.&nbsp;Achieving remission is again possible for most people with MPA.[294][298]<br />","dateModified":"2016-07-06T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":294,"authors":"","articleTitle":"Microscopic Polyangiitis","bookWebsiteJournalTitle":"Cleveland Clinic Web site","date":"2/27/2014","volume":"","pages":"","url":"http://my.clevelandclinic.org/health/diseases_conditions/hic_Microscopic_Polyangitis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":298,"authors":"Farid-Moayer M","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"Medscape","date":"December 21, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/334024-overview","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":21331,"abbreviatedInquiry":"My 12-year-old son was recently diagnosed with microscopic polyangiitis, presenting with acute renal failure. I need information regarding cause, treatment, and prognosis. I am specifically interested in information on&nbsp;pediatric cases of this disorder.","caseQuestions":[{"questionId":423,"questionText":"What is microscopic polyangiitis (MPA)?","answerText":"<strong>Microscopic polyangiitis (MPA) </strong>is a disorder that causes blood vessel inflammation (<a href=\"http://www.nlm.nih.gov/medlineplus/vasculitis.html\" target=\"_blank\">vasculitis</a>),&nbsp;which can lead to&nbsp;organ damage.[294]&nbsp;The kidneys, lungs, nerves, skin, and joints are the most commonly affected areas of the body. MPA is diagnosed in people of all ages, all&nbsp;ethnicities, and both genders.[295] The cause of this disorder is unknown.","dateModified":"2014-08-13T00:00:00","references":[{"referenceId":294,"authors":"","articleTitle":"Microscopic Polyangiitis","bookWebsiteJournalTitle":"Cleveland Clinic Web site","date":"2/27/2014","volume":"","pages":"","url":"http://my.clevelandclinic.org/health/diseases_conditions/hic_Microscopic_Polyangitis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":295,"authors":"","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"The Johns Hopkins Vasculitis Center Web site","date":"2014","volume":"","pages":"","url":"http://www.hopkinsvasculitis.org/types-vasculitis/microscopic-polyangiitis/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":424,"questionText":"What are the symptoms of microscopic polyangiitis (MPA)?","answerText":"The symptoms of MPA depend on which blood vessels are involved and what organs in the body are affected. The most common symptoms of&nbsp;MPA include&nbsp;kidney inflammation, weight loss, skin lesions, nerve damage, and fevers.[295] Other symptoms depending on the area(s) of the body affected may include:[298]<br />\r\n<ul>\r\n    <li>Skin-Rash</li>\r\n    <li>Lungs-cough, breathing problems, spitting up blood</li>\r\n    <li>Gastrointestinal-bleeding in the gastrointestinal tract, abdominal pain</li>\r\n    <li>Brain/neurological-tingling, pain, weakness, loss of sensation, seizures</li>\r\n    <li>Musculoskeletal-joint pain, muscle pain</li>\r\n</ul>","dateModified":"2016-07-06T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":295,"authors":"","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"The Johns Hopkins Vasculitis Center Web site","date":"2014","volume":"","pages":"","url":"http://www.hopkinsvasculitis.org/types-vasculitis/microscopic-polyangiitis/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":298,"authors":"Farid-Moayer M","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"Medscape","date":"December 21, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/334024-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":425,"questionText":"What causes microscopic polyangiitis (MPA)?","answerText":"The cause of MPA is unknown. It is not contagious, does not usually run in families, and is not a form of cancer. The <a href=\"http://kidshealth.org/parent/general/body_basics/immune.html\" target=\"_blank\">immune system</a> is thought to play a critical role in the development of&nbsp;MPA.&nbsp; It is thought that&nbsp;the immune system becomes overactive and causes blood vessel and tissue inflammation, which leads to organ damage.&nbsp;It is not&nbsp;known what causes&nbsp;the immune system to become overactive.[294]","dateModified":"2014-08-13T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":294,"authors":"","articleTitle":"Microscopic Polyangiitis","bookWebsiteJournalTitle":"Cleveland Clinic Web site","date":"2/27/2014","volume":"","pages":"","url":"http://my.clevelandclinic.org/health/diseases_conditions/hic_Microscopic_Polyangitis","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":426,"questionText":"How might microscopic polyangiitis (MPA) be treated?","answerText":"The treatment of MPA is dependent on the extent of the disease, rate of progression, and the degree of inflammation. The goal of treatment is to stop organ damage that occurs as a result of MPA and involves use of medications that suppress the immune system. Treatment is typically carried out in three phases:[294][295][298]<br />\r\n<ol>\r\n    <li>Remission induction using <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601102.html\" target=\"_blank\">prednisone</a> and <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682080.html\" target=\"_blank\">cyclophosphamide</a>. This phase usually lasts between 4 and 6 months.&nbsp;</li>\r\n    <li>Remission maintenance using prednisone and replacing cyclophosphamide with other medications such as <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682019.html\" target=\"_blank\">methotrexate</a> and <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682167.html\" target=\"_blank\">azathioprine</a>. This phases usually lasts between 12 and 24 months.&nbsp;</li>\r\n    <li>Treatment of relapse utilizing medications from phase one or other therapies such as <a href=\"http://primaryimmune.org/treatment-information/immunoglobulin-therapy/\" target=\"_blank\">intravenous immunoglobulin</a> for resistant cases.&nbsp;</li>\r\n</ol>\r\n<br />","dateModified":"2016-07-06T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":294,"authors":"","articleTitle":"Microscopic Polyangiitis","bookWebsiteJournalTitle":"Cleveland Clinic Web site","date":"2/27/2014","volume":"","pages":"","url":"http://my.clevelandclinic.org/health/diseases_conditions/hic_Microscopic_Polyangitis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":295,"authors":"","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"The Johns Hopkins Vasculitis Center Web site","date":"2014","volume":"","pages":"","url":"http://www.hopkinsvasculitis.org/types-vasculitis/microscopic-polyangiitis/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":298,"authors":"Farid-Moayer M","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"Medscape","date":"December 21, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/334024-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":427,"questionText":"What is the long-term outlook for microscopic polyangiitis (MPA)?","answerText":"The prognosis for MPA depends on the severity of the condition. Early diagnosis and prompt treatment lead to a better overall prognosis.[294] With treatment,&nbsp;75 percent of individuals&nbsp;achieve complete remission.[298] After achieving remission, it is possible for MPA to recur (often referred to as a &ldquo;relapse&rdquo;). Relapses occur in about 30-50% of people with MPA.&nbsp;Achieving remission is again possible for most people with MPA.[294][298]<br />","dateModified":"2016-07-06T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":294,"authors":"","articleTitle":"Microscopic Polyangiitis","bookWebsiteJournalTitle":"Cleveland Clinic Web site","date":"2/27/2014","volume":"","pages":"","url":"http://my.clevelandclinic.org/health/diseases_conditions/hic_Microscopic_Polyangitis","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":298,"authors":"Farid-Moayer M","articleTitle":"Microscopic polyangiitis","bookWebsiteJournalTitle":"Medscape","date":"December 21, 2014","volume":"","pages":"","url":"http://emedicine.medscape.com/article/334024-overview","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":428,"questionText":"Do children diagnosed with microscopic polyangiitis (MPA)&nbsp;receive different treatment or have a different prognosis than adults?","answerText":"Limited information is available on pediatric vasculitis and how it differs from vasculitis in adults. Most decisions regarding the treatment of children with MPA are made by using data obtained from research on adults.[297] The Childhood Arthritis Rheumatology Research Alliance conducted research on the feasibility of establishing a registry of children with chronic systemic vasculitis for participation in future research.[296] The abstract for this article is available through <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17117484?ordinalpos=1&amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum\" target=_blank>PubMed</a>. You may wish to contact this organization to learn more about pediatric vasculitis research.<br><br>Childhood Arthritis Rheumatology Research Alliance<br>Dept. of Pediatrics, Div. of Rheumatology<br>300 Pasteur Drive<br>Boswell Building A081<br>Stanford, CA 94305-5208<br>Phone: 650-736-4364<br>Fax: 650-736-4344<br>Online email: <a href=\"http://www.carragroup.org/contact_view.do\" target=_blank>http://www.carragroup.org/contact_view.do</a><br>Web site: <a href=\"http://www.carragroup.org/\" target=_blank>http://www.carragroup.org/</a>","dateModified":"2013-07-22T14:58:00","resourceClassificationName":"Prognosis","references":[{"referenceId":296,"authors":"","articleTitle":"","bookWebsiteJournalTitle":"Wilkinson NM, Page J, Uribe AG, Espinosa V, Cabral DA. Establishment of a pilot pediatric registry for chronic vasculitis is both essential and feasible: a Childhood Arthritis and Rheumatology Alliance (CARRA) survey. J Rheumatol. 2007 Jan;34(1):224-6.","date":""},{"referenceId":297,"authors":"","articleTitle":"","bookWebsiteJournalTitle":"Yalcindag A, Sundel R. Vasculitis in childhood. Curr Opin Rheumatol. 2001 Sep;13(5):422-7.\n\n","date":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":4355,"phenoTypeName":"Autoimmunity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11167,"phenoTypeName":"Erythema","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":1889,"phenoTypeName":"Glomerulopathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":14161,"phenoTypeName":"Hematuria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13737,"phenoTypeName":"Hemoptysis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11700,"phenoTypeName":"Oliguria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10015,"phenoTypeName":"Renal insufficiency","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8270,"phenoTypeName":"Skin rash","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13800,"phenoTypeName":"Vasculitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13419,"phenoTypeName":"Abdominal pain","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7919,"phenoTypeName":"Arthralgia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8110,"phenoTypeName":"Gastrointestinal hemorrhage","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6085,"phenoTypeName":"Gastrointestinal infarctions","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13403,"phenoTypeName":"Nausea and vomiting","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13764,"phenoTypeName":"Peritonitis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":967,"phenoTypeName":"Skin ulcer","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15564,"phenoTypeName":"Subcutaneous hemorrhage","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10903,"phenoTypeName":"Venous thrombosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14446,"phenoTypeName":"Abnormal retinal vascular morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11774,"phenoTypeName":"Arrhythmia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5670,"phenoTypeName":"Arthritis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4779,"phenoTypeName":"Congestive heart failure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10292,"phenoTypeName":"Cutis marmorata","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11716,"phenoTypeName":"Episcleritis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5714,"phenoTypeName":"Epistaxis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1833,"phenoTypeName":"Gangrene","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3874,"phenoTypeName":"Pancreatitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5592,"phenoTypeName":"Paresthesia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3852,"phenoTypeName":"Pericarditis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9832,"phenoTypeName":"Sinusitis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4066,"phenoTypeName":"Subcutaneous nodule","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9144,"phenoTypeName":"Uveitis","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[{"productId":534,"genericName":"Rituximab","tradeName":"Rituxan","tradeLink":"https://www.rituxanforgpampa.com/","manufacturer":"","sponsor":"Genentech, Inc.","indication":"For the use of Rituxan (rituximab) in combination with glucocorticoids for the treatment of pateints with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA).","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/rituxan","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a607038.html"}],"EncodedName":"Microscopic_polyangiitis"}